Uncategorised – Page 32 – Market Industry Forecast News

Ecg Patch And Holter Monitor Market: Monitoring Segment Is Expected To Register The Fastest Growth

ECG Patch And Holter Monitor Industry Overview

The global ECG patch and holter monitor market size is expected to reach USD 4.8 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 19.58% from 2023 to 2030. The Growing prevalence of cardiac arrhythmia, increasing demand for ambulatory monitoring devices, and technological advancements are likely to drive the market during the forecast period.

Recent technologies in ECG patch and Holter monitor market include ECG chip, which can be inserted in the body to record heart rhythms for a long duration; ECG data management solutions; and telemetry. ECG patch and Holter monitor are also used in noncardiology departments, such as electrophysiology labs and nursing & emergency departments, as well as management of respiratory disorders. Initiatives such as the Door-to-Balloon (D2B) time by the American College of Cardiology (ACC) and “Mission: Lifeline” by AHA are expected to drive demand for wireless solutions and 12-lead ECG devices.

COVID-19 pandemic has resulted in high burden on public health and health care delivery globally. The disease has major effects on cardiovascular system. A wide range of arrhythmias have been reported in patients, which complicate the course of COVID-19 due to the associated treatments. Due to the redistribution of health care resources, access to emergency services, such as reperfusion therapy, may be affected, based on severity of the diseases at a local level. Apart from obtaining EUA for innovative products, the market also witnessed strategies such as mergers & acquisitions focused on strengthening solutions offerings, including connected care and remote patient monitoring due to their increased demand during the COVID-19 pandemic. Acquisitions made by Philips of BioTelemetry in December 2020 and Capsule Technologies, Inc. in January 2021 are a few such events.

ECG Patch And Holter Monitor Market Segmentation

Grand View Research has segmented the global ECG patch and holter monitor market based on product, application, end use, and region:

Based on the Product, the market is segmented into ECG Patch, and Holter Monitors.

The healthcare ECG Patch dominated the product segment with a revenue share of 57.60% in 2022. The segment is also expected to exhibit the highest CAGR of 24.72% during the forecast period., which can be attributed to high accuracy, ease of use, and continuous monitoring that helps detect rare arrhythmias. In addition, technological advancements and new product launches for real-time results are likely to drive the market.
Holter monitors are the most commonly used device for extended ECG recording. It uses a conventional tape recorder or solid-state storage system for acquiring ECG information that can be reviewed. According to a study published in NCBI, globally, atrial fibrillation is the most common form of cardiac arrhythmia.

Based on the Application, the market is segmented into Diagnostics, and Monitoring.

The monitoring segment is expected to exhibit the highest CAGR of 19.96% during the forecast period, which can be attributed to high accuracy, and continuous monitoring for detecting rare arrhythmia. In addition, technological advancements, and new product launches for real-time results are factors likely to drive the market.
The manufacturers are engaging in activities such as mergers & acquisitions to strengthen their monitoring solutions portfolio in the market. In November 2021, Philips acquired Cardiologs, a French medical technology company. The acquisition will help the company make use of Cardiologs’ artificial intelligence model that can interpret data from various monitoring devices, including ECG patches, Holter monitors, and smartwatch to generate medical reports.

Based on the End Use Insights, the market is segmented into Hospitals & Clinics, Ambulatory Facilities, and Others.

In 2022, the hospitals and clinics segment accounted for the highest market share of 47.89% and is expected to exhibit the highest CAGR of 20.06% during the forecast period. This can be attributed to well-equipped infrastructure, availability of advanced devices, a rise in the number of practitioners & patients, and an increase in collaborations to help reduce the burden of diagnosis & treatment.
Technological advancements, shifting interest toward ambulatory centers for treatment, and availability of advanced devices like ECG patches & portable Holter for ambulatory ECG monitoring have led to an increase in the number of patients opting for diagnosis in the ambulatory facilities, driving the market growth.

Key Companies & Market Share Insights

The market is highly competitive with the presence of well-established global brands. iRhythm Technology, Inc. is among the key players operating in the ECG patch segment. This can be attributed to the availability of its ZIO patch service products and the development of innovative products through strong investment in R&D. The company provides medical devices, such as resting ECG patch devices for real-time and continuous monitoring. In May 2021, iRhythm Technologies, Inc. announced the receipt of two additional 510(k) certifications-one for a redesigned and improved flagship monitor and another for enhanced Artificial Intelligence (AI) capabilities. Some of the prominent players in the global ECG patch and holter monitor market include:

Nissha Medical Technologies (NMT)
Medtronic plc
Hill-Rom
iRhythm Technologies, Inc.
Nihon Kohden Corporation
Koninklijke Philips N.V.
GE Healthcare
Fukuda Denshi Co., Ltd.
Spacelabs Healthcare
AliveCor, Inc.
Cardiac Insight Inc.
VitalConnect
LifeSignals, Inc.
Bardy Diagnostics, Inc.
Nasiff Associates, Inc.
Midmark Corporation
Lief Therapeutics, Inc.
Schiller AG

Order a free sample PDF of the ECG Patch And Holter Monitor Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Veterinary Equipment And Disposables Market: Companion Animals Segment Dominated The Animal Type Segment

Veterinary Equipment And Disposables Industry Overview

The global veterinary equipment and disposables market size is expected to reach USD 4.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.0% from 2023 to 2030. Increasing pet health expenditure and growing concern among pet owners are driving the market. Advancement in veterinary equipment and growing initiatives by the industry players are boosting the growth. Companies are investing in the expansion of their manufacturing facilities, which is expected to positively influence the revenue over the forecast period. For instance, in June 2021, Veterinary Instrumentation (VI), announced an expansion in the U.S. market. With this expansion, VI is going to bring the support of the expert team to veterinarians and more than 4,000 professional veterinary instruments in the U.S. This initiative is expected to boost the company’s growth, as it allows brand development in North America.

Growth in the companion animal population is expected to increase the demand for better treatment options and boost the overall expenditure on pets. In addition, there is an increase in the demand for animal products in emerging economies, due to improving per capita income and living standards. This has raised concern for the health of livestock which is further fueling the market. Like other markets, the market for veterinary equipment and disposables has also been significantly affected. Some of the major negative impacts of COVID-19 on the market are supply chain disruptions and operational hurdles due to changing policies and restrictions.

Veterinary Equipment And Disposables Market Segmentation

Grand View Research has segmented the global veterinary equipment and disposables market on the basis of product, animal type, end use, and region:

Based on the Product, the market is segmented into Critical Care Consumables, Anesthesia Equipment, Fluid Management Equipment, Temperature Management Equipment, Rescue & Resuscitation Equipment, Research Equipment, and Patient Monitoring Equipment.

The critical care consumables segment dominated the market for veterinary equipment and disposables and held the largest revenue share of over 30.0% in 2022. The growth can be attributed to increasing usage of the consumables for various applications such as wound management, airway management, gastroenterology, reproduction, and others.
The rescue and resuscitation equipment segment is expected to show the fastest growth over the forecast period. Managing cardiopulmonary arrest requires quick patient assessment, with immediate implementation of Cardiopulmonary Resuscitation (CPR) in cats and dogs.

Based on the Animal Type Insights, the market is segmented into Companion Animal, and Livestock Animal.

The companion animals segment dominated the market for veterinary equipment and disposables in 2022. Growth in the companion animal population, rising emphasis on pet care, and wellness by pet owners are contributing to the growth of this segment.
The dogs segment held the largest market share of the companion animals segment in 2022. The dominant share captured by this is a consequence of the increased number of surgeries. The growing incidence of chronic diseases in dogs is one of the major drivers for the market.

Based on the End-use Insights, the market is segmented into Veterinary Hospitals/Clinics, and Research Institutes.

The veterinary hospitals/clinics segment dominated the market for veterinary equipment and disposables in 2022. The growth can be attributed to the availability of a wide range of treatment options in veterinary hospitals and clinics. Various government animal welfare organizations have issued guidelines for safety practices and standards to be implemented in hospitals, which has broadened the scope for segment growth over the past few years.
The research institutes segment is expected to show lucrative growth over the forecast period. Better critical care treatment options for small animals have triggered the demand for research activities which is expected to drive the segment over the forecast period.

Key Companies & Market Share Insights

The market players are constantly involved in strategic initiatives such as new product launches, regional expansion, and mergers and acquisitions to gain deeper penetration. For instance, in July 2021, Covertrus, Inc. entered into an agreement to acquire VCP. VCP is a global leader in animal health technology and services. Likewise in December 2020, Imbed Biosciences Inc. revealed that it formed an exclusive distribution deal with Jorgensen Laboratories to sell its MicroLyte VET wound dressing product to veterinary clinics and hospitals in Canada and the U.S. Initiatives like these are expected to boost the market growth in the coming years. Some of the prominent players in veterinary equipment and disposables market include:

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Smiths Medical, Inc.
Nonin Medical, Inc.
Digicare Biomedical
Covetrus, Inc.
B. Braun Melsungen AG
DRE Veterinary
Vetland Medical Sales and Services
Midmark Corporation
Jorgensen Labs
Grady Medical
Vetronic Services
RWD Life Science Co.,LTD

Order a free sample PDF of the Veterinary Equipment And Disposables Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Meningococcal Vaccines Market: Asia Pacific Region Is Expected To Witness The Highest CAGR

Meningococcal Vaccines Industry Overview

The global meningococcal vaccines market size is expected to reach USD 4.92 billion by 2030, registering a CAGR of 6.2%, according to a new report by Grand View Research, Inc. Increasing prevalence of meningitis is one of the major factors attributed to the market growth. For instance, according to ECDC, it was estimated that in 2017, 3,221 confirmed cases were observed in EU member states, wherein 58% cases were found in the U.K., France, Spain, and Germany. Moreover, a high incidence of meningitis disease is found in the “meningitis belt” of sub-Saharan Africa, and approximately 30,000 cases are reported every year in this region.

In addition, rising FDA approval for meningococcal vaccines is expected to boost the growth. For instance, in April 2020, Sanofi received FDA approval for its MenQuadfi Meningococcal Conjugate Vaccine for the prevention of invasive meningococcal disorders in individuals at least two years old. The increase in approval of novel vaccines is expected to improve meningococcal prevention which in turn, is anticipated to drive the market.

Initiatives undertaken by the government to combat the rising incidence of the disease are anticipated to boost the meningococcal vaccine market growth. For instance, from April 2019, Nimenrix was made available for free as a part of the National Immunization Program (NIP) in Australia for the age group 15 to 19 years. Nimenrix is a quadrivalent meningococcal vaccine that targets serogroups A, C, W & Y.

According to WHO, as of 2021, 24 of the 26 nations in the meningitis belt have introduced mass preventive campaigns targeting the age of 1 to 29 years. Moreover, around 13 nations have undertaken the vaccine in their national routine immunization programs. Such initiatives undertaken by countries having high disease burdens are expected to boost the market growth.

Non-profit organizations entering into strategic initiatives such as partnering, alliances, and others to improve access to new vaccines for vulnerable children are anticipated to drive the market. For instance, in September 2021, WHO and its partners announced the first-ever global strategy to defeat meningitis. This initiative aims to reduce epidemics of bacterial meningitis. Under this strategy, WHO goals to save more than 200,000 lives annually.

The availability of vaccines at lower prices in countries with an increasing prevalence of the meningococcal disease is anticipated to fuel the revenue of the manufacturers and drive the meningococcal vaccine market. For instance, under Meningitis Vaccine Project, MenAfriVac costs less than USD 0.5 per dose.

Meningococcal Vaccines Market Segmentation

Grand View Research has segmented the meningococcal vaccines market based on type, brand, serotype, age group, sales channel, and region:

Based on the Type, the market is segmented into Bivalent, Quadrivalent, and Others.

Quadrivalent vaccines accounted for the largest revenue share in 2021 owing to widely used brands such as Menactra, Menveo, and Nimenrix. Moreover, approval of new vaccines to protect people against meningococcal vaccines is anticipated to fuel the growth of this market.
Bivalent vaccines held the second largest market share owing to the high adoption rate coupled with the low cost and inclusion of these vaccines in various programs undertaken by governments of different countries.

Based on the Brand, the market is segmented into Menactra, Menveo, Nimenrix, Trumenba, Bexsero, and Others.

Bexsero accounted for the largest revenue share in 2021 owing to fewer doctor visits, lower costs and reduced doses. Bexsero is licensed in more than 40 countries, such as New Zealand, Argentina, Chile, Australia, Israel, Uruguay, Turkey, and Europe, and is intended for individuals aged 2 months & above.
rumenba is expected to grow at the fastest rate over the forecast period. The growth of the vaccine is mainly driven by the increasing awareness of the disease and increasing marketing approval across the globe.

Based on the Age Group, the market is segmented into Infants (0 to 2 years), and Children And Adults (2 years & above).

The infants segment is expected to be the fastest-growing segment over the forecast period owing to the rising prevalence of meningitis. For instance, according to European Centre for Disease Prevention and Control (ECDC), in 2017, IMD incidence was observed to be the highest in infants.
The children & adults segment held the largest market share owing to initiatives undertaken by healthcare organizations to vaccinate the adult population and ongoing clinical trials to develop novel vaccines for teenagers. For instance, in February 2020, ACIP released recommended Immunization Schedule for adults, with changes to the administration of the meningococcal B conjugate vaccines.

Based on the Serotype, the market is segmented into Serotype A, Serotype B, Serotype C, Serotype W-135, and Serotype Y.

Serotype B is the predominant agent causing meningococcal disease. It causes around half of the total reported cases of meningococcal disease in these regions. Moreover, increasing research activities to develop pentavalent vaccines including protection against serotype B is further expected to increase the market growth over the forecast period.
The serotype C segment is anticipated to experience the fastest growth over the forecast period. The growth of the segment can be attributed to the high effectiveness of vaccines and the increasing inclusion of vaccines in vaccination programs of countries.

Based on the Sales Channel, the market is segmented into Private, and Public.

The public sales channel segment held the largest market share and is anticipated to maintain its dominance throughout the forecast period. A large share of the segment can be attributed to the inclusion of major meningococcal vaccine brands, such as Trumenba, Bexsero, Menactra, Nimenrix, Menveo, and others in immunization programs in a major market for vaccination against meningococcal infections.
The private sales channel is mainly driven by increasing demand for meningococcal vaccines in developing countries. Moreover, increasing disposable income, increasing outbound traveling from work, study, pilgrims for Mecca and Umrah, and increasing awareness is driving the demand for vaccination against meningococcal vaccines through private sales channels.

Key Companies & Market Share Insights

The key players that dominated the global market in 2021 include GlaxoSmithKline plc and Pfizer Inc. The market is expected to experience a shift in the dynamics over the forecast period due to the presence of strong pipeline products. Moreover, companies are involved in developing novel vaccines for meningococcal disease and expanding the application of existing vaccines in terms of age groups. For instance, in June 2020, Pfizer Inc. started Phase III clinical trials of PF-06886992, which is a pentavalent meningococcal vaccine candidate (MenABCWY). Some prominent players in the global meningococcal vaccines market include:

Pfizer Inc.
Sanofi
Serum Institute of India Ltd.
GlaxoSmithKline plc.
Merck & co., Inc.
Walvax Biotechnology Co., Ltd.

Order a free sample PDF of the Meningococcal Vaccines Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Walking Aids Market Size, Share & Trends Analysis Report 2022 – 2030

Walking Aids Industry Overview

The global walking aids market size is expected to reach USD 4.2 billion by 2030 at a CAGR of 7.1%, according to a new report by Grand View Research, Inc. The market is expected to witness significant growth during the forecast period owing to the increasing disability rates caused due to rising incidence of malnutrition and infectious, non-infectious, & congenital diseases; growing prevalence of diabetes; and increasing geriatric population & number of accidents/traumas.

The introduction of devices with new features such as rollators with the attached laser for Parkinson’s patients is anticipated to propel market growth over the forecast period. The rise in disposable income coupled with an increase in awareness in developed countries is anticipated to further boost market demand.

The high prevalence of osteoporosis & arthritis and increasing awareness & adoption of canes, crutches, & walkers are expected to drive market growth during the forecast period. Moreover, factors such as technological advancements, an increasing number of initiatives & funding by governments & international organizations, and a rising number of post-surgery rehabilitation programs are likely to contribute to market growth.

In addition, the demand for better quality, more efficient, sustainable, and cost-efficient walking aids is rising owing to the increasing number of disabled individuals participating in the workforce. Therefore, urging the need for advanced and cost-effective walking aids. However, the lack of reimbursement and the availability of a wide range of refurbished products in the market is restraining the market growth.

Walking Aids Market Segmentation

Grand View Research has segmented the global walking aids market based on type, and region:

Based on the Type, the market is segmented into Rollators, and Others.

Rollators held the largest market share in 2021, accounting for more than 67.2% of the total market revenue. The ability of rollators wheel to eliminate the need for lifting the device and enable directional control is further facilitating its usage over the forecasted period.

The global walking aids market is divided into rollators and others. This segment is anticipated to witness lucrative growth over the forecasted period due to the high prevalence of osteoporosis & arthritis, increasing awareness, and increasing adoption of canes, crutches, & walkers.

Key Companies & Market Share Insights

New product development, distribution channel enhancement, and collaboration are some of the key strategic initiatives undertaken by these market players. For instance, in September 2021, TOPRO acquired the entire share capital of AssiTech. The acquisition will complete the existing product offering of the company. Some of the prominent players in the global walking aids market include:

HUMAN CARE
Evolution Technologie
Invacare Corporation
Benmor Medical
Carex Health Brands
Eurovema AB
TOPRO
Briggs Healthcare
Drive medical design

Order a free sample PDF of the Walking Aids Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Asia Pacific Nutritional Supplements Market: Functional Foods And Beverages Product Segment Held The Largest Revenue Share

Asia Pacific Nutritional Supplements Industry Overview

The Asia Pacific nutritional supplements market size is expected to reach USD 240.6 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.1% from 2022 to 2030. The population across countries in the Asia Pacific region is gradually shifting towards a healthier lifestyle and the adoption of nutritional supplements as a part of healthy dietary habits to achieve health and fitness goals. The geriatric population in the Asia Pacific region has grown in the past few years, thus increasing the overall burden of chronic diseases. Unhealthy eating habits and increasingly sedentary lifestyles have given rise to a plethora of lifestyle diseases, which are quite prevalent in the Asia Pacific region. As the awareness regarding nutritional needs has been increasing among the population, nutritional supplementation to improve and maintain health has gained a lot of popularity.

The Asia Pacific region has been known for its traditional medicine and healing with the help of natural products. For centuries, these products have been used by the region’s population. In recent years, these traditional products have gained a lot of traction in the Asia Pacific region as well as in other countries. This rise in popularity has led to wider adoption of these products and has led to the nutritional supplements market growth. The increase in disposable incomes across the region has resulted in higher purchasing power. With the increasing awareness regarding nutritional supplements, the market has been growing and is capable of expanding at a substantial rate. COVID-19 has spurred this industry to a great extent and people across the globe have become more aware of the implications of a lack of good immunity. A report by FMCG Gurus states that more than 55% of the APAC population has become more conscious regarding immunity due to COVID-19.

Sports nutrition has piqued a lot of interest in people around the globe. More and more people are opting for sports supplements to achieve their fitness goals. Sports enthusiasts and professional athletes are increasingly promoting supplements through social networking sites and their uptake has risen in recent years, which is a key driving factor for the growth of the nutritional supplements market in Asia Pacific. According to Euromonitor, a Lifestyles survey 2021, more and more millennials have been participating in physical activities and health-related behaviors on a daily basis. The Asia Pacific has been recognized as one of the fastest-growing markets for wellness by Euromonitor and it is expected that the investments in products related to dietary supplements, healthy foods, beverages, and sports nutrition will increase over time, given the growth prospects in the Asia Pacific region.

Asia Pacific Nutritional Supplements Market Segmentation

Grand View Research has segmented the Asia Pacific nutritional supplements market on the basis of product, consumer group, formulation, sales channel, and country:

Based on the Product, the market is segmented into Sports Nutrition, Dietary Supplements, and Functional Foods and Beverages.

The functional foods and beverages segment held the largest revenue share of over 50.0% in 2021. The category consists of probiotics, Omega-3, fatty acids, and other products. Probiotics have been in demand since they promote a healthy gut, resulting in lesser changes in the stomach and GI-related chronic problems.
The sports nutrition segment is expected to expand at a significant growth rate over the forecast period due to an increase in the number of people moving towards a fitter and active lifestyle.

Based on the Consumer Group, the market is segmented into Infants, Children, Adults, Pregnant, and Geriatric

The adult segment captured the largest revenue share of over 25.0% in 2021. The adult population due to their inactive lifestyles and rapid urbanization has become more predisposed to getting chronic diseases like diabetes, hypertension, and cardiovascular diseases.

The children segment is expected to register the fastest growth rate of 7.2% in the forecast period. The major products aimed at this category are meant for good physical and mental growth.

Based on the Formulation, the market is segmented into Tablets, Capsules, Powder, Soft gels, Liquid, and Others

The powder formulation segment held the largest revenue share of over 35.0% in 2021 owing to the growing market for sports nutrition. The majority of the products in the segment like protein and amino acid supplementation are in powder formulations.

The capsule formulation segment is expected to register a lucrative growth rate in the forecast period. This is due to the fact that functional food supplements like Omega-3 and certain probiotics are all in capsule formulations and functional foods in themselves are a large segment in the market.

Based on the Sales Channel, the market is segmented into Brick & Mortar and E-commerce

The brick and mortar segment held the largest revenue share of over 70.0% in 2021. A large number of people are still purchasing through brick-and-mortar stores. However, online sales or e-commerce platform has been gaining a lot of momentum.
E-commerce platforms have been increasingly gaining a lot of traction due to COVID restrictions and lockdowns and initiatives taken by the market players to collaborate with e-commerce platforms for the sale of their products in an effort to reach a wider consumer base. All of these factors have contributed to the growth of the market.

Key Companies & Market Share Insights

Asia Pacific has been a market leader in the nutritional supplements market. The region has the presence of both regional as well as multinational players. The market with respect to consumers is still an immature market and has a significant growth potential owing to the increasing awareness among people regarding fitness and health and increasing purchasing power. COVID-19 has had a lasting impact on the market landscape and has accelerated the growth to a great extent. Some prominent players in the Asia Pacific nutritional supplements market include

Nestle
Abbott
Glanbia plc
Herbalife International
Amway
PepsiCo
Cliff Bar & Company
Science in Sports

Order a free sample PDF of the Asia Pacific Nutritional Supplements Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Global Poultry Vaccines Market Analysis On The Basis Of Application, Product, Disease Type, And Region

Poultry Vaccines Industry Overview

The global poultry vaccines market size is expected to reach USD 3.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.40% from 2023 to 2030. The key factors driving the market include the rising consumption of poultry meat and eggs, the prevalence of avian diseases, and the increasing poultry population in key markets. According to OECD-FAO Agricultural Outlook, poultry meat consumption in the U.S. was pegged at 19,169 thousand tons in 2020. This consumption is projected to increase over the next few years.

The COVID-19 pandemic resulted in several challenges for the poultry industry including a fall in consumption, increased concerns over zoonoses, and low sales. For example, as per the Economic Times, in March 2020, the price of chicken plunged by as much as 70% due to the reduced consumption of meat, fish, eggs, and chicken. However, the pandemic also led to the rising awareness regarding diseases in animals and increasing demand for safe and healthy poultry products. This is anticipated to create opportunities for poultry vaccines manufacturers as poultry farms must ensure healthy layer, broiler, and breeder stock. In fact, in April 2021, the CEO & MD of Hester Biosciences Ltd. stated that the market for poultry vaccines is set to grow significantly post COVID.

In addition, the advent of new vaccines, such as Salmonella-vectored vaccines, which protect domesticated birds against necrotic enteritis is anticipated to provide a growth platform to this market. In addition, the rising usage of poultry vaccines by research institutes and colleges, along with vaccination awareness programs, is fueling the growth of the market. For instance, in July 2019, the Veterinary College and Research Institute based in Madurai, India started vaccinating domesticated birds, predominantly chickens, to save farmers from suffering significant losses.

Technological advancements in poultry vaccines, rising demand for animal protein, concerns over food safety, animal welfare, and microbial resistance, increased focus on avian healthcare, and shift from treatment to the prevention of diseases are some of the other factors anticipated to create growth opportunities in the market. For instance, the TAbic Vaccines Line by Phibro Animal Health Corporation comprises 25+ vaccines for poultry for protection against Newcastle disease, infectious bronchitis, and other poultry diseases.

Poultry Vaccines Market Segmentation

Grand View Research has segmented the global poultry vaccines market on the basis of application, product, disease type, and region:

Based on the Application, the market is segmented into Broiler, Layer, and Breeder.

The breeder segment held the largest revenue share of over 35.0% in 2022. The breeder segment is expected to exhibit the fastest growth rate during the forecast period owing to the increasing number of breeder farms producing fertile eggs, which are hatched in a hatchery.
The policy aimed to enhance the production from layers and commercial broilers and encourage the processing of eggs and chickens, thereby promoting export activities. Such favorable initiatives by the government are further driving the market.

Based on the Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines.

The attenuated live vaccines segment held the largest revenue share of over 30.0% in 2022. These types of vaccines can trigger the immune system to produce a greater number of antibodies as compared to other types of vaccines.
The recombinant vaccines and inactivated vaccines are one of the fastest growing segments in the coming years. The key factors contributing to this growth include product developments and safety benefits associated with inactivated and recombinant vaccines in comparison to live attenuated vaccines.

Based on the Disease Type, the market is segmented into Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Coccidiosis, Avian Influenza, Marek’s Disease, Newcastle Disease, Salmonella, Avian Encephalomyelitis, and Fowl Cholera.

The salmonella diseases segment accounted for the largest revenue share of over 8.0% in 2022. The Egg Drop Syndrome (EDS) segment is expected to expand at the fastest CAGR over the forecast period. This is owing to the high prevalence of Salmonella and Egg Drop Syndrome diseases in poultry animals.
The most common type of vaccine for salmonella is the attenuated Salmonella strains, which can serve as effective as well as safe oral carrier vaccines for preventing necrotic enteritis by expressing heterologous antigens.

Key Companies & Market Share Insights

The market has been characterized by immense competition owing to the presence of local and global players trying to increase their penetration via different strategic moves such as new product development, M&A, JV, partnerships, and distribution channel agreements. For instance, in July 2019, Ceva acquired IDT Biologika GmbH’s veterinary biopharmaceutical as well as R&D business. Additionally, Boehringer Ingelheim launched the VAXXITEK HVT+IBD+ND vaccine in January 2020, to protect poultry against Newcastle Disease, Marek’s Disease, and Infectious Bursal Disease (classic and variant types). Some prominent players in the global poultry vaccines market include:

Boehringer Ingelheim International GmbH
Ceva
Zoetis
Elanco
Merck & Co., Inc.
Hester Biosciences Limited
Vaxxinova International BV
Venkys India
Calier
KM Biologics
Phibro Animal Health Corporation

Order a free sample PDF of the Poultry Vaccines Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

U.S. Companion Animal Health Market: Veterinary Hospitals And Clinics End-Use Segment Held The Largest Revenue Share

U.S. Companion Animal Health Industry Overview

The U.S. companion animal health market size is expected to reach USD 11.3 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.3% from 2023 to 2030. The rising number of pet owners seeking better healthcare services, healthier quality foods, and high-end grooming and training services for their companion animals is a major driver for this market. According to theNational Pet Owners Survey, 90.5 million families in the U.S. own a pet, out of which 69.0 million own a dog. Moreover, high-income families amounted to approximately 60% of the total spending. In recent years, pet adoption has shown immense growth. This is primarily attributed to the fact that people are healthier and happier in the presence of pets, as found by the Human-Animal Bond Research Initiative Foundation (HABRI).

With the rising adoption of companion animals and growing concerns over their health, there comes a direct association with pet insurance. Presently, pet insurance accounts for a small segment in the insurance industry. The Covid-19 pandemic positively impacted the market growth in the U.S. Key players such as Boehringer Ingelheim Animal Health, Chewy, Elanco, MWI Animal Health, Covetrus, and PetIQ focused on expanding their telemedicine solutions into the market as governments relaxed governance to enable more flexible veterinary examinations during the coronavirus pandemic.

Approval of novel therapeutics and companion animal vaccines continues to present this market with lucrative growth opportunities. Ongoing trends for the adoption of e-commerce, pet insurance, veterinary telemedicine, point of care diagnostic testing, and digitalization of veterinary practices are further accelerated by the crisis of COVID-19.

Groundbreaking technological advances are rapidly transforming the pet health industry. These expansions are maximizing the potential for growth. Companies are taking strategic initiatives in pet health, such as the adoption of big data, wearable technologies to monitor pet health, and the inclusion of stem cell therapy. Moreover, established players are focusing on expanding their portfolios. For instance, Elanco acquired Bayer AG’s animal health business unit in August 2019.

The U.S. captured a substantial share of the market. The share attained by this country is primarily a consequence of the presence of prominent market players undertaking extensive expansion strategies. Moreover, the increasing number of R&D investments initiated by the companies is one of the key potential growth factors presumed to be responsible for the sizeable share garnered by the U.S.

U.S. Companion Animal Health Market Segmentation

Grand View Research has segmented the U.S. companion animal health market on the basis of animal type, product, distribution channel, and end use:

Based on the Animal Type, the market is segmented into Dog, Cat, Equine, and Others.

The dog segment held the largest revenue share of over 40.0% in 2022 majorly owing to the rising adoption of dogs. Dogs are known to provide numerous health benefits to their owners such as combating depression, reducing stress, and lowering blood pressure.
The cat segment emerged as the second-largest animal type segment in 2022 and is expected to register the fastest growth rate over the forecast period. Cats are highly prone to infections and chronic health issues, such as cardiovascular disorders, diabetes, and kidney problems.

Based on the Product, the market is segmented into Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others.

The vaccines segment is anticipated to grow at a lucrative rate during the forecast period. Vaccination is important for companion animals as it not only safeguards them from epidemics but also protects owners in case of any animal bites.
The diagnostics segment is expected to register the fastest growth rate during the forecast period. Technological advancements in the field of radiology diagnostics such as electronic data capture, the inclusion of AI, and cloud-based storage are anticipated to drive the segment.

Based on the Distribution Channel, the market is segmented into Retail, E-commerce, and Hospital Pharmacy.

Hospital pharmacy held the largest revenue share of over 55.0% in 2022 due to the high accessibility and affordability. The segment is expected to grow at a steady pace owing to the increasing prevalence of epidemics and chronic health ailments among companion animals.
E-commerce is estimated to be the fastest-growing segment owing to the ease of availability, greater accessibility, and less time consumption. E-commerce or online pharmacies eliminate other market intermediaries of the delivery channel, thereby reducing overall costs.

Based on the End-use, the market is segmented into Point-of-care testing/In-house testing, Veterinary Hospitals & Clinics, and Others.

veterinary hospitals and clinics, and pet insurance companies have been collaborating efforts for better and fast reimbursement options, leading to better treatment and increased footfall.
The point-of-care or in-house testing segment is anticipated to register the fastest growth rate over the forecast period owing to the improved access to healthcare services and the ability to provide quick and accurate results.

Key Companies & Market Share Insights

Extensive mergers and acquisitions, product portfolios, geographical expansions, and collaborative research initiatives are strategies undertaken by the leading players. For instance, in July 2019, Zoetis and Colorado State University entered into an agreement for establishing a research lab for the development of new immunotherapies for veterinary patients.

Established players, in an attempt to increase their market presence and strengthen their product offering, are entering into alliances. For example, in April 2019, Merck acquired Antelliq Corporation in order to increase its foothold in animal health monitoring and smart data management for both companion and livestock animals. The market is competitive and the rising penetration of advanced technologies in this space is further anticipated to present this market with promising growth opportunities in the near future. Some prominent players in the U.S. companion animal health market include:

Zoetis
Ceva Santé Animale
Merck & Co., Inc.
Vetoquinol S.A.
Boehringer Ingelheim Gmbh
Elanco
Virbac
Heska
Dechra Pharmaceuticals Plc
Idexx Laboratories, Inc.
Norbrook Inc.

Order a free sample PDF of the U.S. Companion Animal Health Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Portable Toilet Rental Market Is Expected To Expand At A CAGR Of 7.5% From 2022 To 2030

Portable Toilet Rental Industry Overview

The global portable toilet rental market size was valued at USD 18.16 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030. Rise in the demand for cost-effective and low-maintenance portable toilets on account of rapid urbanization and expanding construction sector in developing regions, such as the Asia Pacific, will boost the market growth. The COVID-19 pandemic positively impacted the growth of the market. In the wake of the COVID-19 pandemic, the full effects of cabin fever begin to set in, and camping helped in shaping the perfect antidote. According to Dan Yates, the founder of Pitchup.com, an outdoor accommodation booking website that offers placement at over three thousand campgrounds across five continents, bookings were up by 350% in June 2020, as compared to May 2020.

Rising consumer preference for outdoor recreational activities, such as camping, hiking, sports tournaments, and special events such as weddings, concerts, and festivals, is likely to contribute to market growth over the forecast period. In addition, strict regulations and heavy investments by governments around the world to provide proper sanitation units are boosting the demand for portable restrooms in public places such as parks, malls, and streets.

Gather more insights about the market drivers, restrains and growth of the Global Portable Toilet Rental market

Additionally, there is a significant rise in the construction of residential and social infrastructure which is projected to propel the demand for portable toilet rental services in the foreseeable future. According to World Bank, the global infrastructure investment needs to reach USD 94 trillion by 2040 to keep pace with profound economic and demographic changes across the globe.

However, there can also be instances where the installation of portable toilets is subject to permission from the concerned municipality or city authorities. The permission is granted based on the extent of hygiene that is maintained in and around the portable toilet units, which requires the rental companies to invest significantly in cleaning services. This, in turn, results in a surge in units’ rental fees, which also depends on the number of people a unit has to accommodate.

Furthermore, technological innovation is opening up new avenues for growth in the market. Incorporation of technologies such as 5G, machine learning, cloud services, artificial intelligence (AI), internet of things (IoT), robotics, and green technologies in sanitation products and services is likely to give the market a major boost.

Browse through Grand View Research’s Homecare & Decor Industry Research Reports.

Biodegradable Cutlery Market – The global biodegradable cutlery market size was valued at USD 39.2 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030.

Reusable Water Bottle Market – The global reusable water bottle market was valued at USD 8.92 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030.

Portable Toilet Rental Market Segmentation

Grand View Research has segmented the global portable toilet rental market based on product, application, technology, and region:

Portable Toilet Rental Product Outlook (Revenue, USD Million, 2017 – 2030)

Standard
Luxury

Portable Toilet Rental Application Outlook (Revenue, USD Million, 2017 – 2030)

Construction
Special Events
Recreational
Commercial

Portable Toilet Rental Technology Outlook (Revenue, USD Million, 2017 – 2030)

Vacuum Technology
Gravity Based Technology
Others

Portable Toilet Rental Regional Outlook (Revenue, USD Million, 2017 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Key Companies profiled:

Some of the key players operating in the global portable toilet rental market include:

Sanitech
Satellite Industries, Inc.
ADCO Group
B&B Portable Toilets
PolyJohn Enterprises Corporation
United Site Services Inc.
Biffs, Inc.
Halco Portables
Handi-Can Portable Toilets
West Coast Disposal Ltd.

Order a free sample PDF of the Portable Toilet Rental Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Snacks Market Significant Trend Fueling The Industry Is The Increasing Substitution Of Meals With Snacks

Snacks industry Overview

The global snacks market size was valued at USD 1,450.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 2.7% from 2022 to 2030. The pandemic-induced lockdowns coupled with the global adoption of the work-from-home culture have led to the exponential growth of the snack market in the last two years. This trend is expected to sustain during the forecast period, as snack manufacturers are focusing on product innovations such as healthier and organic products. COVID-19 lockdowns prompted an increase in at-home consumption of food products. COVID-19 lockdown implementations and extensions had given snack products a significant role in households all across the globe. Because more people are working from home, the desire for “on-the-go indulgence” has intensified. Over the previous two years, demand for packaged snacks such as cookies, chips, noodles, and macaroni has increased as the pandemic has encouraged consumers to establish new in-home dining circumstances.

Rising health concerns globally, and the shifting lifestyles and dietary patterns, have fueled demand for a variety of snacking options. A significant trend fueling the industry is the increasing substitution of meals with snacks, as well as the rising demand for vegan, allergen-free snacks. International brands have seized this opportunity of increased demand for snacks, by packaging their products in more convenient ways to extend shelf life and promote on-the-go snack consumption. For instance, U.S.-based Kwik Lok Corp. offers its Eco-Lok closure packaging solution, which enables consumers to reclose the package and consume the snacks later. The industry growth is expected to be aided by innovative food products, flexible packaging solutions that meet customer needs, and busy lifestyles.

Gather more insights about the market drivers, restrains and growth of the Global Snacks market

Consumers have switched their focus from taste and more animal protein to a broader range of product attributes as their consumption patterns have gradually but steadily changed. Shoppers are seeking a mix of processed and fresh products to help them maintain a healthy, balanced diet. Functional snacks are becoming more popular, and the expectations and needs of young demographic customers are evolving at a rapid pace.

Consumers all across the world are becoming more conscious of their snacking habits, shifting toward healthier options such as vegetables and fruit chips, and granola bars because of the metabolic benefits they provide. During the forecast period, the growing demand for food items that aid in weight management owing to the widespread prevalence of obesity in developed countries such as the U.S. and the U.K. is expected to propel the market for healthy snacking choices.

As a result of the pandemic, many snack food private businesses have emerged in the market to meet the increased demand. Snacks are a quick and accessible source of nutrition and energy in developed countries, thus demand for novel snack products is always high. The number of independent working women, dual-income families, and nuclear families is already on the rise across the globe. The demand for convenience meals has increased substantially as a result of this demographic shift. Snack food is widely regarded as the most convenient alternative to regular food, as it may be consumed at any time, thereby propelling snack market demand globally.

Browse through Grand View Research’s Consumer F&B Industry Research Reports.

Coconut Products Market – The global coconut products market size was valued at USD 20.24 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2023 to 2030.

Macadamia Nut Market – The global macadamia nut market size was valued at USD 1.58 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030.

Snacks Market Segmentation

Grand View Research has segmented the global snacks market based on source, distribution channel, and region.

Product Outlook (Revenue, USD Billion; 2017 – 2030)

Frozen & Refrigerated
Fruit
Bakery
Savory
Confectionery
Dairy
Others

Distribution channel Outlook (Revenue, USD Billion; 2017 – 2030)

Supermarkets and Hypermarkets
Convenience Stores
Online
Others

Regional Outlook (Revenue, USD Billion; 2017 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

February 2020: PepsiCo acquired Be & Cheery, one of the largest online snacks companies in China, from Haoxiangni Health Food Co for USD705 million. The acquisition of Be & Cherry marks an important step in the Company’s goal to become China’s leading consumer-centric food and beverage company.

July 2019: The Ferrero Group and its related companies (“Ferrero”), a global confectionary group, completed its acquisition of the cookie, fruit, and fruit-flavored snack, ice cream cone, and pie crust businesses from The Kellogg Company.

Key Companies profiled:

Some of the key players operating in the snacks market include:

General Mills, Inc.
PepsiCo
The Kraft Heinz Company
Nestlé
The Kellogg Company
Unilever
Calbee
Intersnack Group GmbH & Co. KG
Conagra Brands, Inc.
ITC Limited
Grupo Bimbo
Danone
Mars, Incorporated

Order a free sample PDF of the Snacks Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Self-Tanning Products Market: Online Distribution Channel Segment Is Expected To Register The Fastest Growth

Self-tanning Products Industry Overview

The global self-tanning products market size was valued at USD 877.0 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2022 to 2030. Self-tanning products have become increasingly prevalent as consumers have become aware of the health and long-term aesthetic effects of excessive sun exposure. Widespread UVA and UVB exposure is constantly increasing skin cancer cases, which has been playing a vital role in driving the adoption of such products. The COVID-19 pandemic has had a devastating impact on the market as a majority of the customer base is in Europe and North America, which have been severely affected by the pandemic.

However, as markets have slowly started opening, the popularity of the online distribution channel is expected to create a steady demand for self-tanning and cosmetic offerings in the foreseeable future. Rising concerns about skin diseases and other health risks associated with sun exposure will boost the demand for such offerings in the upcoming years. Lotions & gels are among the most used products as these are frequently applied. Apart from benefits such as instant hydration, reduced breakouts, and refreshed skin, lotions & gels are also easy-to-use quick solutions for combating dry skin. These products, most commonly known as sunless tanners, provide the skin a tanned look without exposing it to harmful Ultraviolet (UV) rays.

Gather more insights about the market drivers, restrains and growth of the Global Self-tanning Products market

As consumers shift toward safer cosmetic and beauty offerings, manufacturers are launching innovative and advanced self-tanning products to provide a more realistic tanning experience while also being safe and better for the skin. Major compositions include ingredients that hydrate and nourish the skin so that it looks healthier and rejuvenated. These ingredients include vitamins, essential oils, fruit extracts, and antioxidants, and their popularity has been increasing in recent years, especially among health-conscious consumers. Furthermore, major health organizations are supporting the use of self-tan products over other variants.

For instance, The Centers for Disease Control and Prevention (CDC) promoted the use of self-tan products by considering it as a safer alternative to UV-induced tanning. Moreover, the preference for such products has been observed to be higher among U.S. consumers owing to the growing prevalence of skin diseases, such as skin cancers. According to the American Academy of Dermatology, skin cancer is the most common cancer in the U.S. and about one in five Americans will develop the disease in their lifetime.

Browse through Grand View Research’s Beauty & Personal Care Industry Research Reports.

Anti-wrinkle Products Market – The global anti-wrinkle products market was valued at USD 10.96 billion in 2022 and is projected to register a compound annual growth rate (CAGR) of 8.9% from 2023 to 2030.

Personalized Skin Care Products Market – The global personalized skin care products market size was estimated at USD 26.20 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2023 to 2030.

Self-tanning Products Market Segmentation

Grand View Research has segmented the global self-tanning products market on the basis of product, application, distribution channel, and region:

Self-tanning Products Product Outlook (Revenue, USD Million, 2017 – 2030)

Lotions
Gels
Others

Self-tanning Products Application Outlook (Revenue, USD Million, 2017 – 2030)

Men
Women

Self-tanning Products Distribution Channel Outlook (Revenue, USD Million, 2017 – 2030)

Supermarkets & Hypermarkets
Convenience Stores
Online

Self-tanning Products Regional Outlook (Revenue, USD Million, 2017 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

August 2021: Cosmopolitan launched CosmoSun – a line of cruelty-free, vegan, and nut-free tan products and other sun-care items, in collaboration with Devoted Creations.
January 2021: BONDI Sands launched an eco-friendly pure fake tan with 100% recyclable packaging.

Key Companies profiled:

Some of the key players operating in the global self-tanning products market include:

The Estée Lauder Companies Inc.
L’Oréal
Shiseido Co., Ltd.
St. Tropez
Unilever
Kao Corporation
Beiersdorf AG
Johnson & Johnson Services, Inc.
Avon Products, Inc.
Clarins

Order a free sample PDF of the Self-tanning Products Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com